Medical
La Trobe climbs in ARWU global ranking
La Trobe University is continuing to climb in one of the world’s best recognised rankings – the Academic Ranking of World Universities (ARWU).
The University has placed 307 in the 2019 ARWU results released by ShanghaiRanking today, up 10 places from last year and an increase of more than 193 positions in the last five years.
La Trobe is placed 17th nationally in the ranking and fourth in Victoria.
The University continues to be rated in the top 400 of all three major world university rankings: the ARWU, QS and Times Higher Education World University Rankings, making it among the world’s top 1.2 per cent of universities.
In addition, all University research that was assessed in the 2018 Excellence in Research for Australia evaluation was rated in the top three categories of: at world standard, above world standard or well above world standard.
Deputy Vice-Chancellor (Research and Industry Engagement) Professor Susan Dodds welcomed La Trobe’s improved position in the ARWU ranking, saying it again confirmed the University’s position as a world-leading University for research.
“La Trobe’s global rankings growth is testament to our exceptional academic staff who are conducting high-impact research addressing some of the biggest challenges of our times, and who are working in close collaboration with industries and research partners across the world,” Professor Dodds said.
The ARWU ranks universities with several indicators of academic or research performance, including alumni and staff winning Nobel Prizes and Fields Medals, highly cited researchers, papers published in Nature and Science, papers indexed in major citation indices, and the per capita academic performance of an institution.
More information on University rankings can be found at the University’s website.
You may also like Therapeutics and the importance of cancer research in Australia
News & Trends - MedTech & Diagnostics
$54 million cancer centre opens in one of Australia’s fastest growing communities
MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreNews & Trends - MedTech & Diagnostics
Queensland elevates diagnostic precision with cutting-edge imaging technology
MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]
MoreNews & Trends - Pharmaceuticals
Landmark collaboration sparks inauguration of precision care clinic
Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]
More